Clinical Trial Update: Influenza Vaccination in Prevention From Acute Coronary Events in Coronary Artery Disease - FLUCAD Study [Phase 2, Phase 3]

View source ↗

Summary

The FLUCAD study, a Phase 2/3 trial, has completed and evaluated whether influenza vaccination can prevent acute cardiovascular events in patients with coronary…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Influenza vaccine (influenza vaccine)

Snippet

Sponsor: National Institute of Cardiology, Warsaw, Poland | Conditions: Coronary Artery Disease | Phase 2, Phase 3 | Status: COMPLETED